Delivery Order SPE2DB20D1110-SPE2DB25FK17A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) valued at $8,107.66 under a firm fixed-price contract type. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supplies to federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $87,741.85 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets in quantities of 30, with a firm fixed price arrangement. This non-set-aside competitive award was executed on September 2, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $51,847.92 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) under a firm fixed-price contract type. This non-set-aside award was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $20,512.96 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) under a firm fixed price contract. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $5,682.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units), with an ultimate completion date of June 3, 2025. This non-set-aside contract represents a competitively awarded pharmaceutical procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $14,837.30 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 MG tablets (30-count units) under a firm fixed-price contract. This award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,012.98 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on September 11, 2025, with completion anticipated by September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $10,629.82 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) with a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by September 24, 2025, one day after the award date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,217.49 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-competitive set-aside delivery against an existing indefinite delivery contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $46,224.65 for Xeljanz XR 11 mg tablets (30-count unit of use packaging) on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's ongoing supply of pharmaceutical products to federal medical procurement needs. The place of performance is...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK17ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,862.72 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) with a firm fixed-price structure. This non-set-aside competitive award was issued on May 30, 2025, with an ultimate completion date of June 2, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen provides critical pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating the company's established capability to fulfill diverse and time-sensitive medical supply requirements across the federal sector.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 5/30/25 |